Related references
Note: Only part of the references are listed.LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells
N. Yokdang et al.
ONCOGENE (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival
B. B. Oven Ustaalioglu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer
Patricia A. Thompson et al.
CANCER RESEARCH (2014)
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
Aoife J. Lowery et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ERα-Positive Breast Cancer
Sheryl R. Krig et al.
MOLECULAR CANCER RESEARCH (2011)
Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer
Patricia A. Thompson et al.
PLOS ONE (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer
Ingrid Ljuslinder et al.
BREAST CANCER RESEARCH (2009)
Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer
Jamie K. Miller et al.
CANCER RESEARCH (2008)
An overview of prognostic factors for long-term survivors of breast cancer
Isabelle Soerjomataram et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Increased copy number at 3p14 in breast cancer
I Ljuslinder et al.
BREAST CANCER RESEARCH (2005)
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation
G Gur et al.
EMBO JOURNAL (2004)
The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases
MB Laederich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials
AC Voogd et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
